Details for New Drug Application (NDA): 021187
✉ Email this page to a colleague
The generic ingredient in NUVARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 021187
Tradename: | NUVARING |
Applicant: | Organon Usa Organon |
Ingredient: | ethinyl estradiol; etonogestrel |
Patents: | 0 |
Pharmacology for NDA: 021187
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 021187
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NUVARING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 021187 | NDA | A-S Medication Solutions | 50090-5611 | 50090-5611-0 | 3 POUCH in 1 BOX (50090-5611-0) / 21 d in 1 POUCH |
NUVARING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 021187 | NDA AUTHORIZED GENERIC | A-S Medication Solutions | 50090-5959 | 50090-5959-0 | 1 POUCH in 1 BOX (50090-5959-0) / 1 d in 1 POUCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
Approval Date: | Oct 3, 2001 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021187
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Organon | NUVARING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 021187-001 | Oct 3, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription